Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection

 Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect SARS-CoV-2 Infection

Abbott’s BinaxNOW COVID-19 Ag Card Receives the US FDA’s EUA to Detect COVID-19

Shots:

  • The US FDA has issued EUA for Abbott’s BinaxNOW COVID-19 Ag Card rapid test for the detection of COVID-19. The test will be available at $5 and can deliver results in 15mins.
  • The test utilizes lateral flow technology and has demonstrated a sensitivity of 97.1% and specificity of 98.5% in a clinical study. Additionally, the company has launched the complementary phone app (NAVICA), allowing people to display their BinaxNOW test results in any organizations where people gather like workplaces and schools
  • The BinaxNOW COVID-19 Ag Card can be used as a 1L of defense to identify infected people. The company anticipates shipping of ~10M tests in Sept, ramping to 50M tests/ month at the beginning of Oct’2020

Click here ­to­ read full press release/ article | Ref: Abbott | Image: Alere